New surgery combo aims to help pancreatic cancer patients finish chemotherapy
NCT ID NCT05116072
First seen Oct 31, 2025 · Last updated May 14, 2026 · Updated 24 times
Summary
This study tests a surgery called total pancreatectomy (removing the whole pancreas) combined with islet cell transplantation (placing insulin-making cells into the liver) for people with pancreatic or related cancers who are at high risk of complications from standard surgery. The goal is to help patients complete their full course of chemotherapy afterward while avoiding severe diabetes. About 36 adults will take part in this early-phase trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA OF THE PANCREAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hop Claude Huriez Chu Lille
RECRUITINGLille, 59037, France
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.